Host-Pathogen Interactions after Lung Transplant: Are Cystic Fibrosis Patients Unique?

Cell Reports Medicine
Eric D Morrell, Erika D Lease

Abstract

The impact of Pseudomonas aeruginosa airway colonization on lung allografts is not entirely clear. In this issue of Cell Reports Medicine, Dugger et al.1 identify distinct clinical outcomes and lung allograft biology in recipients with and without cystic fibrosis.

References

May 1, 1997·American Journal of Respiratory and Critical Care Medicine·R M ArisJ R Yankaskas
Aug 19, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Denis HadjiliadisShaf Keshavjee
Mar 10, 2012·American Journal of Respiratory Cell and Molecular Biology·Dmitry Ratner, Christian Mueller
Apr 1, 2015·Seminars in Respiratory and Critical Care Medicine·Joseph P LynchS Sam Weigt
Dec 15, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Julia PritchardMichael D Parkins
Nov 13, 2017·Clinics in Chest Medicine·Rupal J Shah, Joshua M Diamond

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.